Talon Therapeutics Inc (TLON)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2207 BRIDGEPOINTE PARKWAY SAN MATEO, CA 94404

Hana Biosciences, Inc. is a South San Francisco, CA-based biopharmaceutical company that acquires, develops, and commercializes innovative products that address important unmet medical needs in cancer and immunological diseases. The company states they are committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding their pipeline by being the alliance partner of choice, and nurturing a unique company culture.
Talon Therapeutics is a biopharmaceutical company focused on developing and commercializing new cancer therapies. As of Dec 31 2010, Co. had four product candidates: Marqibo (vincristine sulfate liposomes injection), for the treatment of adult acute lymphoblastic leukemia; Menadione Topical Lotion, for the prevention and/or treatment of the skin toxicities associated with the use of epidermal growth factor receptor inhibitors; Brakiva (topotecan liposome injection), for the treatment of metastatic carcinoma of the ovary and small cell lung cancer sensitive disease; and Alocrest (vinorelbine liposome injection), for the treatment of solid tumors such as non-small-cell lung cancer.

View SEC Filings from TLON instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 125 125 0.0%
% Ownership
New Positions:
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TLON (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TLON BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GHARIB SAMIR M. CONTROLLER, DIRECT. OF FINANCE

  • Officer
No longer subject to file 2013-07-17 0

CARLSON CRAIG W CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2013-07-17 0

DEITCHER STEVEN R PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2013-07-17 0

ROSENBERG LEON E

  • Director
No longer subject to file 2013-07-17 0

MAIER PAUL V

  • Director
No longer subject to file 2013-07-17 0

SPIEGEL ROBERT J.

  • Director
No longer subject to file 2013-07-17 0

FURST HOWARD P.

  • Director
No longer subject to file 2013-07-17 0

PIEN HOWARD H

  • Director
No longer subject to file 2013-07-17 0

DEZAO THOMAS VP, COMM. OPER. & PLANNING

  • Officer
No longer subject to file 2013-07-17 0

WARBURG PINCUS & CO.

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
No longer subject to file 2013-07-16 0

WEATHERMAN ELIZABETH H

  • Director
No longer subject to file 2013-07-16 0

GONZALO CECILIA

  • Director
0 2013-01-25 0

LEFF JONATHAN S

  • Director
0 2012-02-17 0

FERRER ANDREW

  • Director
0 2012-02-17 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • Director
  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
2,951,152 2011-09-26 0

DESILVA NISHAN M

  • Director
0 2011-04-01 0

NIELSEN TYLER MARSHALL CONTROLLER

  • Officer
0 2010-12-31 0

LEFF JONATHAN S

DESILVA NISHAN M

FERRER ANDREW

  • Director
0 2010-06-07 0

HAGEY ANNE E VP, CHIEF MEDICAL OFFICER

  • Officer
0 2010-02-16 0

WEISER MICHAEL

  • Director
561,667 2010-02-16 0

WIESINGER LINDA

  • Director
6,000 2010-02-16 0

BELLDEGRUN ARIE

  • Director
0 2009-02-24 0

IPARRAGUIRRE JOHN VICE PRESIDENT & CFO

  • Officer
16,026 2009-02-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments